Northeast Financial Consultants’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-46,100
| Closed | -$333K | – | 154 |
|
|
2017
Q2 | $333K | Hold |
46,100
| – | – | 0.13% | 110 |
|
|
2017
Q1 | $283K | Hold |
46,100
| – | – | 0.12% | 121 |
|
|
2016
Q4 | $270K | Hold |
46,100
| – | – | 0.12% | 120 |
|
|
2016
Q3 | $245K | Hold |
46,100
| – | – | 0.1% | 131 |
|
|
2016
Q2 | $305K | Hold |
46,100
| – | – | 0.14% | 113 |
|
|
2016
Q1 | $215K | Hold |
46,100
| – | – | 0.11% | 122 |
|
|
2015
Q4 | $233K | Hold |
46,100
| – | – | 0.12% | 109 |
|
|
2015
Q3 | $162K | Hold |
46,100
| – | – | 0.08% | 136 |
|
|
2015
Q2 | $460K | Hold |
46,100
| – | – | 0.21% | 88 |
|
|
2015
Q1 | $587K | Hold |
46,100
| – | – | 0.27% | 73 |
|
|
2014
Q4 | $652K | Sell |
46,100
-2,200
| -5% | -$31.1K | 0.34% | 63 |
|
|
2014
Q3 | $664K | Hold |
48,300
| – | – | 0.36% | 60 |
|
|
2014
Q2 | $742K | Hold |
48,300
| – | – | 0.42% | 55 |
|
|
2014
Q1 | $823K | Sell |
48,300
-3,700
| -7% | -$63K | 0.48% | 48 |
|
|
2013
Q4 | $673K | Buy |
+52,000
| New | +$673K | 0.45% | 42 |
|